Global eClinical Solutions Market

Global eClinical Solutions Market Size, Share, Growth Analysis, By Product(Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), Clinical Trial Management Systems (CTMS)), By Delivery mode(Web-hosted, on-premise), By Development phase(Phase I, phase II), By End-use(Pharma & biotech organizations, contract research organizations) - Industry Forecast 2024-2031


Report ID: SQMIG35G2095 | Region: Global | Published Date: February, 2024
Pages: 265 | Tables: 123 | Figures: 77

Global eClinical Solutions Market News

  • In May 2022, eClinical Solutions announced the release of its elluminate Statistical Computing Environment (SCE), which expands the Elluminate Clinical Data Cloud platform, which integrates and unifies clinical trial data.
  • In May 2022, Emmes launched its third generation Advantage eClinical at the Society for Clinical Trials (SCT) in San Diego from May 15th to 18th. After more than two years of development, Advantage eClinical's cloud platform will be available as a stand-alone software product. The system was specifically designed to provide clinical trial sponsors of all sizes with faster study builds, greater flexibility, and insights.
  • In April 2021, Signant Health expanded its electronic informed consent offerings and enhanced capabilities with the latest release of SmartSignals eConsent. To meet the needs of teams, SmartSignals eConsent solutions are available in three tiers of functionality: silver, gold, and platinum. This strategy has improved the company's existing product offering, resulting in revenue from sales.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

eClinical Solutions Market size was valued at USD 7.18 billion in 2019 and is poised to grow from USD 8.15 billion in 2023 to USD 22.35 billion by 2031, growing at a CAGR of 13.4% in the forecast period (2024-2031).

Global eClinical solutions market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Oracle Corporation', 'Medidata Solutions, Inc.', 'Parexel International Corporation', 'Bioclinica, Inc.', 'OmniComm Systems, Inc.', 'ERT Clinical', 'DATATRAK International, Inc.', 'CRF Health', 'Merge Healthcare, Inc.', 'MedNet Solutions, Inc.', 'Bio-Optronics, Inc.', 'eClinicalWorks LLC', 'ArisGlobal LLC', 'OmniComm Systems, Inc.', 'Anju Software, Inc.', 'Veeva Systems, Inc.', 'Dassault Systemes SE', 'IBM Corporation', 'SAS Institute Inc.', 'PRA Health Sciences, Inc.'

In the field of medical research and novel drug treatments, personalised or gene-based disease management is gaining popularity. When compared to currently available alternative therapies or medications, government reimbursement organisations, commercial insurers, and payers frequently request novel drugs with higher therapeutic value and efficacy, resulting in significant market growth.

Clinical Data Management (CDM) is a critical stage in clinical research that results in the generation of high-quality, reliable, and statistically sound data from clinical trials. This significantly shortens the time between drug development and marketing. Integration of the CDMS with clinical randomization, supply management, trial, and patient recruitment solutions is a strong trend driving this segment.

North America dominated the global eClinical solutions market share, accounting for more than 51% of revenue in 2021, and is likely to maintain the dominant position during the forecast period. A growing target population, combined with an increase in the incidence of lifestyle-related diseases like diabetes and cardiac disorders, is expected to propel market growth. Furthermore, the introduction of new products by eClinical solution vendors, as well as an increase in government grants, are influencing the market in the region during the forecasting years.

eClinical Solutions Market size was valued at USD 7.18 billion in 2021 and is poised to grow from USD 8.15 billion in 2022 to USD 22.35 billion by 2030, growing at a CAGR of 13.4% in the forecast period (2023-2030).

Global eClinical solutions market is highly competitive and somewhat fragmented. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Oracle Corporation', 'Medidata Solutions, Inc.', 'Parexel International Corporation', 'Bioclinica, Inc.', 'OmniComm Systems, Inc.', 'ERT Clinical', 'DATATRAK International, Inc.', 'CRF Health', 'Merge Healthcare, Inc.', 'MedNet Solutions, Inc.', 'Bio-Optronics, Inc.', 'eClinicalWorks LLC', 'ArisGlobal LLC', 'OmniComm Systems, Inc.', 'Anju Software, Inc.', 'Veeva Systems, Inc.', 'Dassault Systemes SE', 'IBM Corporation', 'SAS Institute Inc.', 'PRA Health Sciences, Inc.'

In the field of medical research and novel drug treatments, personalised or gene-based disease management is gaining popularity. When compared to currently available alternative therapies or medications, government reimbursement organisations, commercial insurers, and payers frequently request novel drugs with higher therapeutic value and efficacy, resulting in significant market growth.

Clinical Data Management (CDM) is a critical stage in clinical research that results in the generation of high-quality, reliable, and statistically sound data from clinical trials. This significantly shortens the time between drug development and marketing. Integration of the CDMS with clinical randomization, supply management, trial, and patient recruitment solutions is a strong trend driving this segment.

North America dominated the global eClinical solutions market share, accounting for more than 51% of revenue in 2021, and is likely to maintain the dominant position during the forecast period. A growing target population, combined with an increase in the incidence of lifestyle-related diseases like diabetes and cardiac disorders, is expected to propel market growth. Furthermore, the introduction of new products by eClinical solution vendors, as well as an increase in government grants, are influencing the market in the region during the forecasting years.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global eClinical Solutions Market

Product ID: SQMIG35G2095

$5,300
BUY NOW GET FREE SAMPLE